Guangdong Zhenxi Biotechnology Co., Ltd – Trademark Portfolio

Entity Type: 99

Guangdong Zhenxi Biotechnology Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include XANDOVAL. The owner is based in Huizhou, Guangdong Province.

Zone C, 1F, Plant 1-3, No.7, Hechang East Fourth Road, Zhongkai High-tech Zone,

Huizhou, Guangdong Province 516000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

XANDOVAL
XANDOVAL
Registered 2025

Trademark Classifications

Guangdong Zhenxi Biotechnology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Guangdong Zhenxi Biotechnology Co., Ltd have?

Guangdong Zhenxi Biotechnology Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guangdong Zhenxi Biotechnology Co., Ltd file in?

Guangdong Zhenxi Biotechnology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Guangdong Zhenxi Biotechnology Co., Ltd's most well-known trademarks?

Guangdong Zhenxi Biotechnology Co., Ltd's registered trademark portfolio includes well-known marks such as XANDOVAL. These are among 1 currently registered trademark in the portfolio.

What is Guangdong Zhenxi Biotechnology Co., Ltd's trademark registration success rate?

Guangdong Zhenxi Biotechnology Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.